Table 1.
Patient demographics and baseline characteristics (ITT population Hispanic subjects)
| CLINDAMYCINF-BP 3.75% (N=64) | VEHICLE (N=72) | TOTAL (N=136) | |
|---|---|---|---|
| AGE, Y | |||
| Mean (SD) | 19.7 (6.25) | 21.2 (6.55) | 20.5 (6.43) |
| Median | 18.0 | 20.0 | 19.0 |
| Range | 12–40 | 13–39 | 12–40 |
| Sex, N (%) | |||
| Male | 28 (43.8) | 34 (47.2) | 62 (45.6) |
| Female | 36 (56.3) | 38 (52.8) | 74 (54.4) |
| Race, N (%) | |||
| White/Caucasian | 61 (95.3) | 68 (94.4) | 129 (94.9) |
| Black or African American | 2 (3.1) | 3 (4.2) | 5 (3.7) |
| Multiple/other | 1 (1.6) | 1 (1.4) | 2 (1.5) |
| Evaluator’s Global Severity Score, N (%) | |||
| 0=Clear | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| 1=Almost Clear | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| 2=Mild | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| 3=Moderate | 56 (87.5) | 65 (90.3) | 121 (89.0) |
| 4=Severe | 8 (12.5) | 7 (9.7) | 15 (11.0) |
| 5=Very Severe | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Lesion Counts (mean [SD]) | |||
| Inflammatory | 26.6 (4.71) | 25.8 (5.09) | 26.2 (4.91) |
| Noninflammatory | 33.1 (14.57) | 31.7 (14.11) | 32.3 (14.29) |